OmniAb Business Combination Approved by APAC Shareholders

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. CVS
10. SPY

Go back to OmniAb Business Combination Approved by APAC Shareholders

Ligand Pharma (LGND) PT Lowered to $135 at H.C. Wainwright

October 25, 2022 10:47 AM EDT

H.C. Wainwright analyst Joseph Pantginis lowered the price target on Ligand Pharma (NASDAQ: LGND) to $135.00 (from $310.00) while maintaining a Buy rating.

The analyst commented, "Yesterday, Ligand announced that the combination between OmniAb and Avista Public Acquisition Corp. II (AHPA; not rated) was... More